Eli Lilly, Novo Nordisk, Sanofi Accused Of Artificially Raising Insulin Prices
Arkansas has accused Eli Lilly And Co (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Sanofi SA (NASDAQ:SNY), and three of the largest pharmacy benefit managers (PBMs)…
Price Of Pfizer’s Paxlovid Generic Version Capped At $25 Or Less For Low-Income Countries
Several generic drugmakers will produce cheaper versions of Pfizer Inc’s (NYSE:PFE) COVID-19 antiviral treatment Paxlovid at $25/course or less for…
AbbVie’s Upadacitinib Shows Clinical Response In Crohn’s Disease Maintenance Study At One Year
AbbVie Inc (NYSE:ABBV) announced topline results from U-ENDURE Phase 3 maintenance study evaluating upadacitinib in adult patients with moderate to severe…
Here’s Why RBC Capital Raised Price Target On Cigna
Cigna Corp (NYSE:CI) posted 1Q22 adjusted EPS well above expectations on enterprise-wide growth, with a particularly solid performance in specialty pharmacy…
Moderna Files Motion To Dismiss COVID-19 Vaccine Related Patent Claims: WSJ
Moderna Inc (NASDAQ: MRNA) is trying to fight off rival companies’ patent infringement claims related to its COVID-19 vaccine, arguing that the companies may only pursue their claims by seeking royalties from the federal government.
Barron’s Latest Picks And Pans: Tesla, Sony, Cloudflare, Lucid And This Leading Chipmaker
Benzinga reviews this weekend's top stories on Barron's, for additional information on the latest market news, Benzinga Pro offers a 24/7 news feed, live chat and charting software.
Researchers Want Pfizer’s Therapy Studied As Evidence Suggests Benefit for Long COVID Patients: Reuters
Additional reports of patients with long COVID who were helped by Pfizer Inc's (NYSE: PFE) oral antiviral treatment Paxlovid have surfaced, providing momentum for conducting clinical trials to test the treatment,
Why McKesson Shares Are Jumping Today
McKesson Corp (NYSE:MCK) reported Q4 FY22 adjusted EPS of $5.83, +15% Y/Y, and missing the consensus of $6.04. Revenues increased…
Insulet Q1 Earnings Beats Street View, Says Omnipod 5 Rollout Is ‘Progressing Very Well’
Insulet Corporation (NASDAQ:PODD) posted Q1 profits of $27.8 million, or an EPS of $0.40, beating the consensus of $0.23. Q1…
The Daily Biotech Pulse: Limited Use Of JNJ’s COVID-19 Shot, Myovant-Pfizer’s Relugolix Application Delayed, Gain Therapeutics’ Parkinson’s Data
Here's a roundup of top developments in the biotech space over the last 24 hours.